By Nigam Arora
Surgery Partners (SGRY) owns a large portfolio of surgical facilities across the U.S., including ambulatory surgery centers and short stay surgical hospitals. The company partners with physicians to perform a wide range of procedures in lower cost outpatient settings, benefiting from the ongoing shift away from traditional hospital operating rooms.
On the surface, this looks like a classic value opportunity. Underneath, it is something more complex. The business has real assets, real demand drivers, and real long term potential. At the same time, there is a structural factor that is preventing that value from being realized in a normal way.
Investors need to hold two thoughts at the same time:
- This is a high potential asset trading at a discount.
- It is an asset where the path to unlocking value is uncertain.
Buyout Offer Rejection
Surgery Partners received a $25.75 per share buyout offer. Management rejected the offer stating the stock was worth more and they had a plan to realize higher value over time.
Importantly, management did present what appeared, at the time, to be a highly credible plan that could move SGRY stock into the $35 – $40 range fairly quickly over a few quarters based on execution, margin improvement, and cash flow scaling.
In execution of the plan, management has shown poor judgment, an inability to deliver on stated plans, and inconsistency quarter after quarter.
This is the real reason the stock has fallen. There is a pattern of mistakes, repeated quarter after quarter. Such a pattern often leads management to change. However, that has not happened here.
The reason is structural. Bain Capital, with roughly 39% ownership, effectively controls outcomes. Bain has continued to back the current management team. Part of that dynamic likely reflects board composition, where relationships and alignment with existing leadership reduce the probability of decisive change.
The rejection of the buyout offer therefore did two things:
- Removed a real liquidity event at a premium
- Transferred execution risk entirely onto a management team that has not delivered
The market has responded accordingly.
Control Drives Outcomes
Bain’s roughly 39% ownership does not provide absolute control, but it provides effective control over outcomes. Strategic alternatives cannot proceed without alignment. Activist efforts lack the ownership base to force change, and management decisions are made within a structure where the controlling shareholder’s priorities dominate. This is not a typical public company dynamic.
The result is straightforward. Value can exist, but it is not realized unless and until the controlling shareholder chooses to act.
Industry Tailwinds Are Strong
The broader surgical center industry is healthy:
- Volumes are growing.
- Profitability is attractive.
- More procedures continue to migrate from hospital operating rooms to outpatient surgical centers due to cost efficiency and convenience.
Historically, when a company under performs within a strong industry and owns real assets, the outcome tends to be favorable. Either execution improves, or the assets attract interest, and value is unlocked.
Buying the laggard in a strong industry has often been a successful strategy. That would normally be the call here. However, the control structure changes the equation. The presence of a dominant shareholder makes management change and strategic shifts more difficult, even when the industry backdrop is supportive.
$35 – $40 Potential
Based on industry trends and normalized execution, there is a reasonable path for SGRY to reach the $35 – $40 range over a two to three year period. That scenario assumes improved operational performance, better capital discipline, and a management team that executes with strong judgment.
The complication is not the potential. The complication is the path. With the ownership described above, changing management or accelerating strategic action is not as straightforward as it would be in a more widely held company.
Money Flows
Money flows are extremely negative. Historically, such extreme negative money flows have been a contrary signal and often present a buying opportunity.
However, money flows are not a precise timing tool. They indicate conditions, not timing. In this case, negative flows reflect sustained selling pressure tied to uncertainty, not necessarily capitulation that marks a bottom. Investors should recognize the signal, but not rely on it for timing.
Sentiment
Sentiment is extremely negative. Historically, extreme negative sentiment has been a reliable contrary indicator and often aligns with buying opportunities.
As with money flows, sentiment is not a precise timing signal. Negative sentiment can persist for extended periods, especially in situations where structural factors dominate. The current sentiment reflects frustration, lack of confidence, and absence of near term catalysts.
Insider Selling
Insiders have been selling. Investors need to view this in context. These are the same insiders who presided over the significant value destruction that has already occurred. Their track record of judgment is weak.
Insider selling in this context does not necessarily represent informed timing. It may reflect the same flawed judgment that led to the current situation. However, one point is clear – insider selling signals that current management does not have confidence in near term value realization.
Tax Loss Selling
It is only March, but investors should look ahead. If the stock does not stage a meaningful recovery between now and September, tax loss selling pressure is likely to emerge starting in October. Many funds operate on fiscal years ending October 31.
Typically, such selling creates opportunities to buy into weakness. However, in this case, many investors already hold significant positions. That makes it more difficult to add exposure, particularly given the control dynamics that already limit visibility on value realization.
Why Management Has Not Changed
In most companies, a decline of this magnitude would lead to leadership changes or strategic resets. That has not occurred here. The reason lies in the control structure.
Management stability reflects the view of the controlling shareholder. If that view is that the current team can still deliver long term value, there is no immediate pressure to make changes. This is not an oversight. It is alignment with a longer term plan that does not prioritize near term stock performance.
Two Key Questions
Here are the two key questions investors should be asking:
- Value exists, but will it be allowed to emerge? The assets, industry positioning, and long term demand support a higher valuation. The challenge is not identifying value, but understanding when and how it will be realized within a controlled structure.
- What game is Bain playing? One possible interpretation is that Bain Capital may be allowing the stock to drift lower so that it can acquire the remaining shares at a cheaper price. After taking the company private, Bain could then focus on execution and potentially bring the company public again in two to four years at a much higher valuation, potentially in the $35 – $40 range.
It Is Not A Cakewalk For Bain
If such a strategy is being considered, it is important to recognize that this is not a simple path. This is an inference based on observed behavior and structural incentives. Bain is not communicating such a plan publicly.
There are meaningful constraints. Minority shareholders have legal protections, including rights tied to fair treatment in any take-private transaction. Acquiring the company at a low price would require approval mechanisms that cannot be easily bypassed.
If shareholders are disciplined and refuse to accept a lowball offer, such a strategy becomes difficult to execute. In that case, Bain may need to shift its approach. Instead of relying on a lower takeout price, the path could move toward improving execution and realizing value in a way that benefits all shareholders.
What Now Matters
Traditional valuation frameworks are no longer sufficient. What matters now is evidence of operational stabilization, signals of strategic intent, and any developments that shift the balance between patience and pressure.
SGRY stock offers high potential at current levels. It is a great value on a fundamental basis. The stumbling block is not the business. The stumbling block is the path to realizing that value.
Potential Buyout Target
SGRY has all of the characteristics of a potential buyout target, with one exception. The exception being Bain controls about 39% and nothing is going to happen without Bain’s consent.
Zones
The buy zone to scale in is $*** (To see the locked content, please take a 30 day free trial) to $***.
For those starting a position now, the recommended quantity is ***% – ***% of the full core position size.
The very long term target zone is $35 – $40.
The mental stop zone is $*** to $***.
What To Do Now
Those not in SGRY stock may consider initiating a position by scaling in within the buy zone.
Those in SGRY stock may review the quantity held in the context of the total portfolio. Up to 40% of the full core position size is already being held. If this position is very small relative to the total portfolio, it may make sense to add if the stock dips into the lower third of the buy zone. On the other hand, if the position size is meaningful in the context of the entire portfolio, it may make sense to reduce the position size by scaling out on any up spikes.
Signal Limited is a Signal(s) with a great record in similar situations but does not meet all of the stringent criteria for a Signal. Typically Signal Limited has higher risk-reward compared to a Signal over the short term.
To take a free 30-day trial to paid services to gain access to more opportunities, please click here.
This post was just published on ZYX Buy Change Alert.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 1% of the content from our paid services. …TO RECEIVE REMAINING 99%, INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES AND SIGNALS IN REAL TIME, TAKE A FREE
TRIAL TO PAID SERVICES.
The Arora Report is one of the only major global investment newsletters that does not employ a single salesperson—because it does not need to. While competitors rely on high-pressure sales tactics, The Arora Report grows purely through results, with satisfied members recommending it to their family and friends.
Join the service that investors trust the most and recommend to family and friends.
Please click here to take advantage of a FREE 30 day trial.
Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.
